---
title: "Permanent Daylight Saving Time Would Add Billions of Dark-Morning School Commutes, Study Finds"
id: "medrxiv-1-over-a-billion-more-dark-morning-school-commutes-for-k-12-children-under-the"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-1-over-a-billion-more-dark-morning-school-commutes-for-k-12-children-under-the"
content_type: "clinical_feed_article"
specialty: "Pediatrics"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.24.26361097v1?rss=1"
published_at: "2026-08-27T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Permanent Daylight Saving Time Would Add Billions of Dark-Morning School Commutes, Study Finds
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-1-over-a-billion-more-dark-morning-school-commutes-for-k-12-children-under-the
- **Specialty:** [Pediatrics](https://medichelpline.com/clinical-feed/pediatrics.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.24.26361097v1?rss=1)
- **Published At:** 2026-08-27T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study modeled school departures before sunrise under three time regimes: **permanent standard time (ST)**, the current system (seasonal DST/ST), and **permanent daylight saving time (DST)** using real school start times for 14 states that have enacted permanent DST legislation. - In Washington State, the average school start time was 08:27; under the current system and permanent ST no pre-sunrise departures were required on average, but **permanent DST** would require many pre-sunrise departures during winter. - Using observed school start times, the authors estimate permanent DST would add about **35 million child-days** of pre-sunrise travel in Washington alone relative to the current system. - Extrapolating from real start times and assuming an 08:00 departure for all U.S. public schoolchildren, permanent DST would produce more than **2 billion additional dark-morning commutes** per year nationwide compared with the current system. - Analysis of Seattle traffic-collision data found that the odds a crash involved a pedestrian were **143% higher on dark mornings** (adjusted odds ratio 2.4), indicating elevated pedestrian-crash risk on days with pre-sunrise travel. - The authors conclude that permanent DST would expose many more children, on many more days, to increased pedestrian-crash risk and that these safety consequences should inform decisions about national time policy. - Data and code are maintained in a private GitHub repository to be released upon publication; collision dataset source for Seattle collisions is publicly referenced in the manuscript. - The authors declare no competing interests and state that ethical guidelines and participant consent procedures were followed as applicable.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=wheMp8IfRXYgGRF4SkqTa0Hym2PJpYcPHszyXqSGYCM-1787881497.133732-1.2.1.1-nzsXlr6jAkt6qxmtq8_KYsxTZ4nmtjH4ZQtRKndE48ziOvgSyTNxi6bCKSdBjMgV) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.24.26361097v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Over a Billion More Dark Morning School Commutes for K-12 Children under the Sunshine Protection Act [ View ORCID Profile](http://orcid.org/0000-0002-1151-3616)Guadalupe O Rodriguez Ferrante, Nirekh s Dasika, Alicia Nam, Jessie Lu, Navneet Tumber, Elena Kully-Rivera, Viridian Klei, Daniel Zhang, Micaela E Romero, Horacio O de la Iglesia doi: https://doi.org/10.64898/2026.08.24.26361097 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Guadalupe O Rodriguez Ferrante University of Washington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Guadalupe%2BO%2BRodriguez%2BFerrante%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Rodriguez%20Ferrante%20GO&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGuadalupe%2BO%2BRodriguez%2BFerrante%2B) * [ORCID record for Guadalupe O Rodriguez Ferrante](http://orcid.org/0000-0002-1151-3616 "Open in new tab") * For correspondence: guadarf@uw.edu Nirekh s Dasika University of Washington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nirekh%2Bs%2BDasika%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Dasika%20NS&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANirekh%2Bs%2BDasika%2B) Alicia Nam University of Washington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Alicia%2BNam%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nam%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAlicia%2BNam%2B) Jessie Lu University of Washington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jessie%2BLu%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lu%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJessie%2BLu%2B) Navneet Tumber University of Washington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Navneet%2BTumber%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tumber%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANavneet%2BTumber%2B) Elena Kully-Rivera University of Washington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Elena%2BKully-Rivera%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kully-Rivera%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AElena%2BKully-Rivera%2B) Viridian Klei University of Washington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Viridian%2BKlei%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Klei%20V&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AViridian%2BKlei%2B) Daniel Zhang University of Washington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Daniel%2BZhang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Zhang%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADaniel%2BZhang%2B) Micaela E Romero University of Washington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Micaela%2BE%2BRomero%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Romero%20ME&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMicaela%2BE%2BRomero%2B) Horacio O de la Iglesia University of Washington * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Horacio%2BO%2Bde%2Bla%2BIglesia%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=de%20la%20Iglesia%20HO&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHoracio%2BO%2Bde%2Bla%2BIglesia%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.24.26361097v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1287478/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.24.26361097v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1287478/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.24.26361097v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1287478/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.24.26361097v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1287478/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.24.26361097v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1287478/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract The U.S. House's approval of the Sunshine Protection Act has revived the debate over permanent daylight saving time (DST) versus permanent standard time (ST). Health and sleep organizations favor permanent ST because it benefits health, especially for children with rigid school schedules. Further, permanent DST would push school start times to before sunrise in many regions, leading to dark-morning commutes. However, the safety consequences of this shift remain unquantified. Using real school start times for 14 states that have enacted permanent DST legislation, together with local sunrise time, we counted the school days on which students must leave home before sunrise under permanent ST, the current system, and permanent DST. In Washington State, where schools start on average at 08:27, neither permanent ST nor the current system requires any pre-sunrise departure, whereas permanent DST would for most of the winter. Using real school start-time data, permanent DST would add about 35 million child-days of pre-sunrise travel in Washington alone relative to the current system, with similar patterns across the other 13 states. Extrapolated to all U.S. public schools and assuming an 8:00 departure, permanent DST would generate more than 2 billion additional dark-morning commutes each year relative to the current system. Finally, analyzing Seattle traffic collisions, we found that the odds that a crash involved a pedestrian were 143% higher on dark mornings (adjusted odds ratio 2.4). Permanent DST would therefore expose many more children, on many more days, to elevated pedestrian-crash risk, evidence that deserves consideration as the United States chooses a time standard. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Code and data underlying this study are maintained in a private GitHub repository, which will be made public and archived on Zenodo with a citable DOI upon publication of the manuscript. Prior to that, data are available from the corresponding author upon reasonable request. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.24.26361097v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.24.26361225v1 "Combining A Massively Parallel Reporter Assay and Human Data to Elucidate Genetic Mechanisms Driving Risk for Juvenile Idiopathic Arthritis")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.25.26361356v1 "Real-Time Genomic Epidemiology Approaches to a Measles Outbreak Response in Utah") Posted August 27, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.24.26361097v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/27/2026.08.24.26361097.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.24.26361097v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/27/2026.08.24.26361097.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Over a Billion More Dark Morning School Commutes for K-12 Children under the Sunshine Protection Act Guadalupe O Rodriguez Ferrante, Nirekh s Dasika, Alicia Nam, Jessie Lu, Navneet Tumber, Elena Kully-Rivera, Viridian Klei, Daniel Zhang, Micaela E Romero, Horacio O de la Iglesia medRxiv 2026.08.24.26361097; doi: https://doi.org/10.64898/2026.08.24.26361097 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.24.26361097v1%26text%3DOver%2520a%2520Billion%2520More%2520Dark%2520Morning%2520School%2520Commutes%2520for%2520K-12%2520Children%2520under%2520the%2520Sunshine%2520Protection%2520Act "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.24.26361097v1%26t%3DOver%2520a%2520Billion%2520More%2520Dark%2520Morning%2520School%2520Commutes%2520for%2520K-12%2520Children%2520under%2520the%2520Sunshine%2520Protection%2520Act "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.24.26361097v1%26title%3DOver%2520a%2520Billion%2520More%2520Dark%2520Morning%2520School%2520Commutes%2520for%2520K-12%2520Children%2520under%2520the%2520Sunshine%2520Protection%2520Act%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.24.26361097v1%26title%3DOver%2520a%2520Billion%2520More%2520Dark%2520Morning%2520School%2520Commutes%2520for%2520K-12%2520Children%2520under%2520the%2520Sunshine%2520Protection%2520Act "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.24.26361097) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.24.26361097v1&count=horizontal&via=&text=Over%20a%20Billion%20More%20Dark%20Morning%20School%20Commutes%20for%20K-12%20Children%20under%20the%20Sunshine%20Protection%20Act&counturl=www.medrxiv.org/content/10.64898/2026.08.24.26361097v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (612) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (892) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (325) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4753) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (474) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (406) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (640) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1610) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15803) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1194) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6969) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (726) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1051) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4959) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1422) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1731) * [Hematology](https://www.medrxiv.org/collection/hematology) (578) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1329) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16227) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1158) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (661) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (150) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (718) * [Neurology](https://www.medrxiv.org/collection/neurology) (7161) * [Nursing](https://www.medrxiv.org/collection/nursing) (360) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1072) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1226) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (998) * [Oncology](https://www.medrxiv.org/collection/oncology) (3563) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1032) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (392) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (445) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (464) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (702) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1770) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (730) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (758) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5813) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9665) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2371) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1428) * [Respiratory Medicine](https://www.medrxiv.org/collection/resp
## Related Clinical Research

- [Effectiveness and Safety of Tocilizumab in Refractory Rheumatoid Arthritis: A Moroccan Study](https://medichelpline.com/clinical-feed/medrxiv-12-real-world-effectiveness-and-safety-of-tocilizumab-in-refractory-rheumatoid.md)
- [Case report: ADMIO type 1 linked to de novo STAT3 gain-of-function mutation](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-a-case-report-of-admio-type-1-caused-by-a-de-novo-stat3-gain-of-function.md)
- [Using MPRA and Human Expression Data to Identify Genetic Mechanisms in Juvenile Idiopathic Arthrit](https://medichelpline.com/clinical-feed/medrxiv-16-combining-a-massively-parallel-reporter-assay-and-human-data-to-elucidate.md)
- [Cancer screening and long-term care facilities: gaps highlighted by a missed breast cancer diagnos](https://medichelpline.com/clinical-feed/stat-news-3-opinion-cancer-screening-guidelines-need-to-address-long-term-care-facilities.md)
- [Multiple Long-Term Conditions in India: Prevalence, Quality of Life Impact, and Healthcare Use](https://medichelpline.com/clinical-feed/bmj-open-7-multiple-long-term-conditions-and-their-association-with-quality-of-life-and.md)

## Navigation
- [← Back to Pediatrics Feed](https://medichelpline.com/clinical-feed/pediatrics.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.